These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 893417)

  • 41. [The modification of the prephase of coagulation with dextran 150 in vitro].
    Kuhn W; Graeff H
    Klin Wochenschr; 1965 Dec; 43(23):1281-2. PubMed ID: 5872353
    [No Abstract]   [Full Text] [Related]  

  • 42. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 43. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of charged groups in factor XI/XIa activity.
    Morgan K; Schiffman S
    J Biol Chem; 1982 Oct; 257(19):11284-7. PubMed ID: 6981645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet interaction with the contact system of coagulation.
    Scully MF; Weersinghe KM; Kakkar VV
    Adv Exp Med Biol; 1985; 192():389-98. PubMed ID: 3914835
    [No Abstract]   [Full Text] [Related]  

  • 46. Epidemiologic and clinical data linking factors XI and XII to thrombosis.
    Key NS
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):66-70. PubMed ID: 25696836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identity of contact activation cofactor and Fitzgerald factor.
    Schiffman S; Lee P; Waldmann R
    Thromb Res; 1975 May; 6(5):451-4. PubMed ID: 237340
    [No Abstract]   [Full Text] [Related]  

  • 48. HMW and LMW kininogens.
    Kato H; Nagasawa S; Iwanaga S
    Methods Enzymol; 1981; 80 Pt C():172-98. PubMed ID: 7043190
    [No Abstract]   [Full Text] [Related]  

  • 49. Basic mechanisms in blood coagulation.
    Davie EW; Fujikawa K
    Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
    [No Abstract]   [Full Text] [Related]  

  • 50. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.
    Rai V; Balters MW; Agrawal DK
    Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partial purification of factors XI and XIa: a comparison of their molecular size and structure.
    Connellan JM; Castaldi PA
    Thromb Res; 1975 Nov; 7(5):717-28. PubMed ID: 813327
    [No Abstract]   [Full Text] [Related]  

  • 53. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 54. Coagulation pathways: interrelationships and control mechanisms.
    Bennett B
    Semin Hematol; 1977 Jul; 14(3):301-18. PubMed ID: 69320
    [No Abstract]   [Full Text] [Related]  

  • 55. [Initiation mechanism of blood coagulation (author's transl)].
    Kurachi K; Fujikawa K
    Tanpakushitsu Kakusan Koso; 1980 Feb; 25(2):95-111. PubMed ID: 7008084
    [No Abstract]   [Full Text] [Related]  

  • 56. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
    Revak SD; Cochrane CG; Bouma BN; Griffin JH
    J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rat coagulation factors V, VIII, XI, and XII: vitamin K dependent.
    Owen CA; Bowie EJ
    Haemostasis; 1978; 7(4):189-201. PubMed ID: 658784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.
    Kotronen A; Joutsi-Korhonen L; Sevastianova K; Bergholm R; Hakkarainen A; Pietiläinen KH; Lundbom N; Rissanen A; Lassila R; Yki-Järvinen H
    Liver Int; 2011 Feb; 31(2):176-83. PubMed ID: 21134109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.
    Mashiko H; Kato K; Fujii K; Takahashi H
    Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.